Order Article Reprints

Dupuis-Girod S, Fargeton A-E, Grobost V, Rivière S, Beaudoin M, Decullier E, Bernard L, Bréant V, Colombet B, Philouze P, et al. Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial. Journal of Clinical Medicine. 2020; 9(5):1262. https://doi.org/10.3390/jcm9051262

Dupuis-Girod, Sophie, Anne-Emmanuelle Fargeton, Vincent Grobost, Sophie Rivière, Marjolaine Beaudoin, Evelyne Decullier, Lorraine Bernard, Valentine Bréant, Bettina Colombet, Pierre Philouze, and et al. 2020. "Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial" Journal of Clinical Medicine 9, no. 5: 1262. https://doi.org/10.3390/jcm9051262

Dupuis-Girod, S., Fargeton, A.-E., Grobost, V., Rivière, S., Beaudoin, M., Decullier, E., Bernard, L., Bréant, V., Colombet, B., Philouze, P., Bailly, S., Faure, F., & Hermann, R. (2020). Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial. Journal of Clinical Medicine, 9(5), 1262. https://doi.org/10.3390/jcm9051262